Introduction: Few studies have been published to date exploring the effectiveness of
ketamine for treatment-resistant depression (TRD) in large clinical samples. We report on …

Objective: Ketamine has demonstrated rapid antidepressant effects in patients with
treatment-resistant depression (TRD); however, the safety and tolerability of ketamine in this …

Background Little is known about the long-term outcomes of repeated ketamine infusions for
depression. We conducted a retrospective chart review to investigate outcomes of …

Background Though intravenous (IV) ketamine and intranasal (IN) esketamine are noted to
be efficacious for treatment-resistant depression (TRD), access to each of these treatments …

Background Sub-anaesthetic administration of ketamine is an emerging practice in patients
presenting treatment resistant depression (TRD), however several outstanding questions …

Background The effectiveness, tolerability, and safety of intravenous (IV) ketamine in adults
with treatment resistant depression (TRD) receiving care in real-word settings is insufficiently …

BACKGROUND: A single subanesthetic (intravenous) IV dose of ketamine might have rapid
but transient antidepressant effects in patients with treatment-resistant depression (TRD) …

Background Ketamine has emerged as a rapid-acting antidepressant in treatment-resistant
depression (TRD) increasingly used in non-research, clinical settings. Few studies …

Background Little is known about the antidepressive effects of repeated intravenous
ketamine infusions beyond the acute phase of treatment in patients with refractory …

Objective: Subanesthetic ketamine doses have been shown to have rapid yet transient
antidepressant effects in patients with treatment-resistant depression, which may be …